IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW LEADERSHIP BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW LEADERSHIP BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR Ardelyx to Participate at the Cowen 42nd Annual Health Care Conference Read more about Ardelyx to Participate at the Cowen 42nd Annual Health Care Conference Ardelyx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights Read more about Ardelyx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights Ardelyx Announces $27.5 Million Debt Financing Agreement with SLR Capital Partners Read more about Ardelyx Announces $27.5 Million Debt Financing Agreement with SLR Capital Partners Ardelyx to Report Fourth Quarter and Year-End 2021 Financial Results and Provide Corporate Update on February 28, 2022 Read more about Ardelyx to Report Fourth Quarter and Year-End 2021 Financial Results and Provide Corporate Update on February 28, 2022 Ardelyx, Inc. Reports Employment Inducement Grants Read more about Ardelyx, Inc. Reports Employment Inducement Grants Ardelyx Launching IBSRELA® Second Quarter of 2022 Read more about Ardelyx Launching IBSRELA® Second Quarter of 2022 Ardelyx Reports Third Quarter 2021 Financial Results Read more about Ardelyx Reports Third Quarter 2021 Financial Results Ardelyx to Present at the Jefferies London Healthcare Conference Read more about Ardelyx to Present at the Jefferies London Healthcare Conference Ardelyx Reports Additional Positive Data Supporting Clinical Utility of Tenapanor at ASN's Kidney Week 2021 Read more about Ardelyx Reports Additional Positive Data Supporting Clinical Utility of Tenapanor at ASN's Kidney Week 2021 Ardelyx to Pursue Formal Dispute Resolution for Tenapanor Read more about Ardelyx to Pursue Formal Dispute Resolution for Tenapanor Pagination First page « First Previous page ‹ Previous … Page 6 Page 7 Page 8 Page 9 Current page 10 Page 11 Page 12 Page 13 Page 14 … Next page Next › Last page Last » Subscribe to FAQs Email Alerts Connect
Ardelyx to Participate at the Cowen 42nd Annual Health Care Conference Read more about Ardelyx to Participate at the Cowen 42nd Annual Health Care Conference
Ardelyx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights Read more about Ardelyx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
Ardelyx Announces $27.5 Million Debt Financing Agreement with SLR Capital Partners Read more about Ardelyx Announces $27.5 Million Debt Financing Agreement with SLR Capital Partners
Ardelyx to Report Fourth Quarter and Year-End 2021 Financial Results and Provide Corporate Update on February 28, 2022 Read more about Ardelyx to Report Fourth Quarter and Year-End 2021 Financial Results and Provide Corporate Update on February 28, 2022
Ardelyx, Inc. Reports Employment Inducement Grants Read more about Ardelyx, Inc. Reports Employment Inducement Grants
Ardelyx Launching IBSRELA® Second Quarter of 2022 Read more about Ardelyx Launching IBSRELA® Second Quarter of 2022
Ardelyx Reports Third Quarter 2021 Financial Results Read more about Ardelyx Reports Third Quarter 2021 Financial Results
Ardelyx to Present at the Jefferies London Healthcare Conference Read more about Ardelyx to Present at the Jefferies London Healthcare Conference
Ardelyx Reports Additional Positive Data Supporting Clinical Utility of Tenapanor at ASN's Kidney Week 2021 Read more about Ardelyx Reports Additional Positive Data Supporting Clinical Utility of Tenapanor at ASN's Kidney Week 2021
Ardelyx to Pursue Formal Dispute Resolution for Tenapanor Read more about Ardelyx to Pursue Formal Dispute Resolution for Tenapanor